The Combination of Lithium and L-Dopa/Carbidopa Reduces MPTP-induced Abnormal Involuntary Movements (AIMs) via Calpain-1 Inhibition in a Mouse Model: Relevance for Parkinson׳s Disease Therapy

Brain Research - Netherlands
doi 10.1016/j.brainres.2015.06.018
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

The Sigma-1 Antagonist BMY-14802 Inhibits L-Dopa-Induced Abnormal Involuntary Movements by a WAY-100635-sensitive Mechanism

Psychopharmacology
Pharmacology
2009English

Abnormal Involuntary Movements in the Elderly

British Journal of Psychiatry
MedicinePsychiatryMental Health
1982English

Stereotactic Thalamotomy and L-Dopa Induced Involuntary Movement in Parkinsonism

Neurologia Medico-Chirurgica
SurgeryNeurology
1973English

L-Dopa and Carbidopa (Sinemet) in the Management of Parkinsonism

Postgraduate Medical Journal
Medicine
1975English

Delayed O-Methylation of L-Dopa in MB-COMT-deficient Mice After Oral Administration of L-Dopa and Carbidopa

Xenobiotica
PharmacologyBiochemistryMutagenesisHealthMedicineToxicology
2017English

Chloroquine-Induced Involuntary Movements.

BMJ
1977English

The Effects of Central Aromatic Amino Acid DOPA Decarboxylase Inhibition on the Motor Actions of L-Dopa and Dopamine Agonists in MPTP-treated Primates

British Journal of Pharmacology
Pharmacology
2000English

Dysrhythmia of Timed Movements in Parkinson׳s Disease and Freezing of Gait

Brain Research
NeuroscienceNeurologyDevelopmental BiologyMolecular Biology
2015English

Entacapone Improves the Availability of L-Dopa in Plasma by Decreasing Its Peripheral Metabolism Independent of L-Dopa/Carbidopa Dose

British Journal of Clinical Pharmacology
Pharmacology
2002English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy